Liver Transplant
Conditions
Interventions
None listed
Sponsors
Mimetech S.r.l.
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Countries
Italy
Outcome results
None listed
NEurotrophins MImetic compound for modulation of ischemia/reperfusion damage in Liver transplantation with Extended criteria Donors, a phase I/II explorative, open label, controlled, randomized study
For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms
Source: EU CTIS · Data processed: Feb 4, 2026